Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 31INDUSTRY 4OTHER_GOV 1FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 107Neoplasms 70Colorectal Neoplasms 51Uterine Cervical Neoplasms 41Prostatic Neoplasms 32Stomach Neoplasms 31Motor Activity 26Carcinoma, Hepatocellular 24Lung Neoplasms 22Rectal Neoplasms 21Colonic Neoplasms 19Head and Neck Neoplasms 18Pancreatic Neoplasms 17Brain Neoplasms 15Pain 14Polycystic Ovary Syndrome 13Recurrence 12Pain, Postoperative 11Lymphoma 11Esophageal Neoplasms 11Anxiety Disorders 11Ovarian Neoplasms 10Glioma 10Endometrial Neoplasms 10Thyroid Neoplasms 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Pilonidal Sinus 9Carcinoma, Non-Small-Cell Lung 9Papillomavirus Infections 8Hematologic Neoplasms 8

Interventions

Nivolumab 1Immune Checkpoint Inhibitors 1Fecal Microbiota Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × OTHER_GOV × Adenocarcinoma Of Esophagus × Clear all
NCT05001360 2021-10-27

Study of FMT Combined With Nivolumab in Gastric Cancer

Fujian Cancer Hospital

Phase NA Withdrawn
Gastrointestinal

Adenocarcinoma Of Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡